The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic Effects

The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic Effects

Programmed death ligand 1 (PD-L1) is an immune checkpoint with a role in cancer-related immune evasion. It is a target for cancer immunotherapy and its expression is detected for the use of some immune checkpoint inhibitors in advanced non-small cell lung cancer patients (NSCLC). Vimentin is a key c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sara Bravaccini, Giuseppe Bronte, Elisabetta Petracci, Maurizio Puccetti, Manolo D’Arcangelo, Sara Ravaioli, Maria Maddalena Tumedei, Roberta Maltoni, Angelo Delmonte, Federico Cappuzzo, Lucio Crinò
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
NSCLC
PD-L1
vimentin
immune infiltrate
non-metastatic (M0) patients
Biology (General)
QH301-705.5
Acceso en línea:https://doaj.org/article/db302667216f4985b2e27f223631df39
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares